# Regeneron Pharmaceuticals, Inc.: Form 8-K, filed Jan 30, 2026

- Company: [Regeneron Pharmaceuticals, Inc.](/companies/regn.md) (CIK 872589)
- Form: 8-K
- Filed: 2026-01-30
- Accepted by EDGAR: Jan 30, 2026, 06:51 ET
- Period: 2026-01-30
- Accession: 0000872589-26-000004
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/872589/000087258926000004/regn-20260130.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/872589/000087258926000004/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/872589/000087258926000004/regn-20260130.htm

Filed Jan 30, 2026.
Source: SEC EDGAR, the filing index for accession 0000872589-26-000004. Last ingested by Listed: Nov 5, 2026, 23:47 ET. No prices; not investment advice.